Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

NCT04393441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease (DED)

Interventions

DRUG: 011516X (New Artificial Tear Formulation)
DRUG: Systane Ultra Multidose
DRUG: REFRESH PLUS®

Sponsor

Allergan